What drove the intraday spike in B8F.DE stock?

The spike reflects concentrated trading on XETRA with **45,797** shares traded. Moves likely stem from block trades, short covering, or speculative reaction to company updates rather than a new earnings release.

What valuation metrics should I watch for Biofrontera AG?

Key metrics include EPS **-0.21**, PE **-32.40** (negative), Price/Sales **0.64**, and EV/EBITDA **3.36**. Monitor cash per share **€0.05** and current ratio **1.76** for liquidity signals.

What price target does Meyka AI give for B8F.DE stock?

Meyka AI's forecast model projects a 12-month base target of **€10.00**, implying **46.92%** upside from **€6.80**. Forecasts are model-based projections and not guarantees.

How should traders approach B8F.DE's volatility?

Expect large intraday swings due to thin float and low average volume. Use tight stops, trade smaller size, and watch for sustained volume above the **605.00** average before adding exposure.

DE Stocks

Biofrontera (B8F.DE XETRA) rises to €6.80 intraday 03 Feb 2026: heavy volume may set trend

ByHuzaifa Zahoor February 3, 2026February 3, 2026

Intraday action shows B8F.DE stock trading at €6.80 on XETRA on 03 Feb 2026 on unusually heavy volume. The move follows a wide intraday range from €0.30 to €6.80, with reported volume at 45,797 shares versus an average volume of 605. Traders are reacting to liquidity and recent company developments while the stock trades well above its 50-day average of €6.53 and below its 200-day average of €9.19. We summarise the drivers, valuation, technicals, and what the Meyka AI model projects for the next 12 months.